IM

ImageneBio Inc

IMA · Nasdaq

ImageneBio Inc (IMA) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for ImageneBio Inc in 2026. The next earnings report is expected on November 11, 2026.

Earnings calendar

Next earnings date

11 Nov 2026

In 82 days

EPS estimate

-0.72

Revenue estimate

0

Past earnings

05 Aug 2026
EPS actual
-0.63 (+35.5%)
estimate -0.98
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
07 May 2026
EPS actual
-0.95 (-42.5%)
estimate -0.67
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
10 Mar 2026
EPS actual
-0.62 (+55.1%)
estimate -1.38
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
12 Nov 2025
EPS actual
-2.91 (-104.3%)
estimate -1.42
Revenue actual
0
estimate 0
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Beat Miss usd

Latest earnings analysis

ImageneBio Inc beat consensus estimates in its latest earnings report, with EPS of $-0.63 versus an estimate of $-0.9767 and revenue met expectations at $0. In the prior report EPS missed expectations while revenue met expectations.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Clinical-stage biotechnology company developing differentiated therapies for immunological/autoimmune & inflammatory (I&I) diseases, notably non‑depleting anti‑OX40 monoclonal antibody IMG‑007 in Phase 2b for atopic dermatitis

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Kristin Yarema
Employees
10
IPO date
27 Feb 1998
ISIN
US45175G2075
Website
inmagenebio.com

Frequently asked questions

When does ImageneBio Inc (IMA) next report earnings?

ImageneBio Inc (IMA) is scheduled to report earnings on November 11, 2026.

What was ImageneBio Inc's most recent earnings date?

ImageneBio Inc (IMA) last reported earnings on August 5, 2026.

Where is ImageneBio Inc stock listed?

ImageneBio Inc (IMA) is listed on Nasdaq.